Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Scientists hunt for immune clues to endometriosis

NCT ID NCT07078435

First seen Nov 01, 2025 · Last updated Jun 23, 2026 · Updated 35 times

Summary

This study will compare immune cells and gut bacteria in 40 women with and without endometriosis. Researchers hope to find biological markers that explain why the disease develops and worsens. The goal is to pave the way for new treatments that target the immune system rather than just hormones.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MICROBIOTA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • CHUGA

    Grenoble, Isère, 38000, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact Email: •••••@•••••

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this study could identify immune or microbiome markers that lead to new, non-hormonal treatments for endometriosis.

What could go wrong

This is a small, early observational study, not a treatment trial. It may not find clear biomarkers, and any potential therapies would need many more years of testing.

Conditions

The condition(s) this trial relates to.

endometriosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.